Header Logo

A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.

A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Adv Neurol. 1983; 37:75-83.

View in: PubMed